Dermata Therapeutics, Inc.

US$0.76As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:DRMAHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (84.91%)
Div yield —
ROE (183.89%)
Biotechnology
Beta (5Y) 0.58
PE TTM —
TSR TTM (77.66%)
Mkt cap US$3.073M
ROIC (118.12%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.945
23.67%
65.17%
Hold 7|7|7|3|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
2.21%
11.25%
1.10%
8.12%
Revenue$M
0.182
0.189
0.199
0.200
14.38%
18.24%
17.89%
15.41%
Peers (US$3.073M)
Cap (US$)
PE
3.015M
—
2.990M
—
Capital
TTM
5Y
10Y
Leveragex
0.853
2.157
2.036
EBIT/Intx
0.812
0.134
0.134
Own earn%
21.31
(23.16)
(26.69)
Sh yield%
35.08
26.72
18.25
Owners
Insiders/Inst%
3.90
81.00
Short interest%
4.31
SBC / revenue%
5.31
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
3–12
$1 testx
—
Incr. ROIC%
3